retatrutide phase 2 trial obesity nejm 2023 triple agonist 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ retatrutide phase 2 trial new

It also supports energy levels and cognitive performance, helping reduce fatigue and mental fog

Semaglutide for Weight Loss in Beverly Hills - R3 SlimSTAT Our modern medspa is conveniently located in Beverly Hills, the expert medical team at R3 Anti-Aging & Medspa Beverly Hills provides cutting-edge nonsurgical services focused on total body rejuvenation and optimal health, including: Stem Cell Therapies Using your bodys own healing stem cells to repair joints, reduce inflammation, restore hair growth, and more

Many patients notice reduced appetite early in treatment, with continued progress over time when combined with healthy nutrition, regular physical activity, and lifestyle changes

For instance, patients with a history of pancreatitis should exercise caution, and those with personal or family histories of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid GLP-1 receptor agonists, as rodent studies have indicated a potential risk of thyroid tumors